Stock Stars Look Under The Surface

Influential New York-hedge fund manager Ricky Sandler returns to Australia to make a new pick at this year’s Sohn Hearts & Minds conference that will be held at the Sydney Opera House on November 17.
Eminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John Feder

Eric Johnston

Stock Stars Look Under The Surface

September 11, 2023
Influential New York-hedge fund manager Ricky Sandler returns to Australia to make a new pick at this year’s Sohn Hearts & Minds conference that will be held at the Sydney Opera House on November 17.
Read Transcript

Investors looking for signs of another bull market will be waiting for some time, says influential New York-hedge fund manager Ricky Sandler.

Even so, stock pickers shouldn’t be sitting around trying to ride the momentum but instead focus on the “much more interesting things happening beneath the surface,” says Sandler, the founder and chief executive of $US7bn ($11bn) Eminence Capital.

Sandler quickly emerged on the radar of a number of Australian investors as the fund boss delivered one of the top performing stock picks at last year’s Sohn Hearts & Minds investment manager conference. For players like Sander, who has a third of the funds he runs under a short strategy, the real opportunities are in individual stocks rather than the broad market. And a big shift in the drivers of shares over the past two decades has delivered significant opportunity.

Investors need to look through the momentum of the market and focus in the details of individual stocks. Picture: Getty Images

Here he points to the fast-paced rise of passive investing through ETFs or other index trackers, and this has meant that shareholder pressure is not being exerted to the degree it once was.

 Compounding this is thematic-based investing or environment, social and governance-only funds that have a narrower mandate, which means pressure is not always being applied in the right place.

With shareholder votes being increasingly outsourced to proxy advisers, this has given boards and management the space to be “either uninterested or lazy or just not acting in the best interest of long-term shareholder returns,” Sandler says.

Most estimates of the US market have passive funds sitting with ETFs or index trackers at around 18-20 per cent of share holdings. In some companies it can reach as much as 50 per cent. More recent analysis points out real estate is among the most passively-owned sectors.

This means inside any market there may be a lot of stocks moving around “not necessarily based on their long-term fundamentals”.

 “This is creating good opportunities for stock pickers that have kind of adjusted to this new world,” Sandler says.

New picks

Sandler returns to Australia to make a new pick at this year’s Sohn Hearts & Minds conference that will be held at the Sydney Opera House on November 17. The conference, established to raise funds for medical research, is now in its eighth year.

The format of Sohn is relatively simple. Some of the world’s top fund managers take to the stage and present their buy case for a single stock. It is rare for fund managers to go public on their top trading ideas and Sohn shines a light on their investment processes. All the proceeds from the day go directly to Australian medical research.

Conference organisers are hoping to this year pass the $60m mark for funds raised across the eight conferences so far. Last year Sohn went on the road in Hobart and partnered with a number of Tasmanian medical research facilities.

The Sohn conference puts fund managers centre stage where they release their best stock pick. Andrew Macken from Montaka Global Investments appears at a previous conference. Picture: Nikki Short

There Sandler picked California-based tech play New Relic, a company that allows organisations to monitor IT systems. He had a fundamental belief that New Relic was undervalued compared to its rivals and its earnings had been “misperceived”.

The tech company has since surged nearly 70 per cent after getting a buyout offer led by private equity play TPG, in a cash deal that values the company at more than $US6.5bn.

When Sandler first started looking at New Relic 15 months ago the San Francisco-based company was losing money, but still returning a healthy profit margin. This was the reason behind the pricing mismatch.

“That situation often creates opportunities for investors like us where we’re looking at the earnings power of a business and other investors are looking at the actual earnings.”

Barrenjoey co-executive chairman and Sohn Australia co-founder Matthew Grounds says Sandler fits the bill in terms of the aim of the conference.

“This is about bringing to Australian investors and the public, the fund managers that they wouldn’t otherwise sort of get the opportunity to see. I think that that’s proof in the pudding because I think it’s pretty clear that Ricky’s fund and his performance and their approach is attractive to the high net worth investors in this part of the world.”

Previous conferences have had names including Berkshire Hathaway’s Charlie Munger, Ray Dalio of Bridgewater Associates, Ark’s Cathie Woods and Bill Ackman of Pershing Square Capital.

“We’re always pushing ourselves to do one better than the last has been,” Grounds says.

Entain pressure

Sandler remains tight-lipped about plans for his November pick. However he has been in the spotlight in recent months given his fund is currently piling activist pressure on UK gaming major Entain, that operates brands Ladbrokes and Neds in Australia. His fund has hit out at Entain’s acquisition spree and its bid to raise cash by selling a large chunk of new shares. He has said this cuts shareholder value and could in turn draw out a takeover for Entain at a deep discount. Sandler’s fund has been adding to the pressure by adding to its stake in Entain.

The Entain case is a template for the type of companies he targets: companies that need to have a change in investor perception.

Sandler’s hedge fund is putting global gaming and wagering operator Entain, which operates Ladbrokes and Neds, under pressure. Picture: Vince Caligiuri/Getty Images

“We’re looking for good companies that will grow and continue to be kind of more profitable and more valuable in the future.

“And I think there’s scope for improvement … it’s a company whose business is pretty solid and healthy, and has a bit of a negative investing perception today that we think can change materially over the next two years.”

China is another area of opportunity given its perception that it is a market that is becoming uninvestable.

“We love when people call entire swathes of things uninvestable because usually there’s some diamonds in the rough.”

Even if US interest rates have hit the peak or still have higher to go in order to curb inflation, the high level of fixed loans among American homeowners and businesses suggests the economy there hasn’t yet seen the full impact of higher rates.

But this will happen over time, which means the market will be range-bound Sandler says. And this means stock pickers will have to work harder in order to deliver outsized returns.

“I think everyone is focused on a soft landing or where’s inflation going to fall and where interest rates are going. Nobody’s focused on picking interesting, idiosyncratic stocks.

“I think the system is healthy enough that I’m not worried about something really bad happening. So we can play offence.”

The Australian is a media partner of Sohn Hearts and Minds.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on 11 September 2023. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Investors looking for signs of another bull market will be waiting for some time, says influential New York-hedge fund manager Ricky Sandler.

Even so, stock pickers shouldn’t be sitting around trying to ride the momentum but instead focus on the “much more interesting things happening beneath the surface,” says Sandler, the founder and chief executive of $US7bn ($11bn) Eminence Capital.

Sandler quickly emerged on the radar of a number of Australian investors as the fund boss delivered one of the top performing stock picks at last year’s Sohn Hearts & Minds investment manager conference. For players like Sander, who has a third of the funds he runs under a short strategy, the real opportunities are in individual stocks rather than the broad market. And a big shift in the drivers of shares over the past two decades has delivered significant opportunity.

Investors need to look through the momentum of the market and focus in the details of individual stocks. Picture: Getty Images

Here he points to the fast-paced rise of passive investing through ETFs or other index trackers, and this has meant that shareholder pressure is not being exerted to the degree it once was.

 Compounding this is thematic-based investing or environment, social and governance-only funds that have a narrower mandate, which means pressure is not always being applied in the right place.

With shareholder votes being increasingly outsourced to proxy advisers, this has given boards and management the space to be “either uninterested or lazy or just not acting in the best interest of long-term shareholder returns,” Sandler says.

Most estimates of the US market have passive funds sitting with ETFs or index trackers at around 18-20 per cent of share holdings. In some companies it can reach as much as 50 per cent. More recent analysis points out real estate is among the most passively-owned sectors.

This means inside any market there may be a lot of stocks moving around “not necessarily based on their long-term fundamentals”.

 “This is creating good opportunities for stock pickers that have kind of adjusted to this new world,” Sandler says.

New picks

Sandler returns to Australia to make a new pick at this year’s Sohn Hearts & Minds conference that will be held at the Sydney Opera House on November 17. The conference, established to raise funds for medical research, is now in its eighth year.

The format of Sohn is relatively simple. Some of the world’s top fund managers take to the stage and present their buy case for a single stock. It is rare for fund managers to go public on their top trading ideas and Sohn shines a light on their investment processes. All the proceeds from the day go directly to Australian medical research.

Conference organisers are hoping to this year pass the $60m mark for funds raised across the eight conferences so far. Last year Sohn went on the road in Hobart and partnered with a number of Tasmanian medical research facilities.

The Sohn conference puts fund managers centre stage where they release their best stock pick. Andrew Macken from Montaka Global Investments appears at a previous conference. Picture: Nikki Short

There Sandler picked California-based tech play New Relic, a company that allows organisations to monitor IT systems. He had a fundamental belief that New Relic was undervalued compared to its rivals and its earnings had been “misperceived”.

The tech company has since surged nearly 70 per cent after getting a buyout offer led by private equity play TPG, in a cash deal that values the company at more than $US6.5bn.

When Sandler first started looking at New Relic 15 months ago the San Francisco-based company was losing money, but still returning a healthy profit margin. This was the reason behind the pricing mismatch.

“That situation often creates opportunities for investors like us where we’re looking at the earnings power of a business and other investors are looking at the actual earnings.”

Barrenjoey co-executive chairman and Sohn Australia co-founder Matthew Grounds says Sandler fits the bill in terms of the aim of the conference.

“This is about bringing to Australian investors and the public, the fund managers that they wouldn’t otherwise sort of get the opportunity to see. I think that that’s proof in the pudding because I think it’s pretty clear that Ricky’s fund and his performance and their approach is attractive to the high net worth investors in this part of the world.”

Previous conferences have had names including Berkshire Hathaway’s Charlie Munger, Ray Dalio of Bridgewater Associates, Ark’s Cathie Woods and Bill Ackman of Pershing Square Capital.

“We’re always pushing ourselves to do one better than the last has been,” Grounds says.

Entain pressure

Sandler remains tight-lipped about plans for his November pick. However he has been in the spotlight in recent months given his fund is currently piling activist pressure on UK gaming major Entain, that operates brands Ladbrokes and Neds in Australia. His fund has hit out at Entain’s acquisition spree and its bid to raise cash by selling a large chunk of new shares. He has said this cuts shareholder value and could in turn draw out a takeover for Entain at a deep discount. Sandler’s fund has been adding to the pressure by adding to its stake in Entain.

The Entain case is a template for the type of companies he targets: companies that need to have a change in investor perception.

Sandler’s hedge fund is putting global gaming and wagering operator Entain, which operates Ladbrokes and Neds, under pressure. Picture: Vince Caligiuri/Getty Images

“We’re looking for good companies that will grow and continue to be kind of more profitable and more valuable in the future.

“And I think there’s scope for improvement … it’s a company whose business is pretty solid and healthy, and has a bit of a negative investing perception today that we think can change materially over the next two years.”

China is another area of opportunity given its perception that it is a market that is becoming uninvestable.

“We love when people call entire swathes of things uninvestable because usually there’s some diamonds in the rough.”

Even if US interest rates have hit the peak or still have higher to go in order to curb inflation, the high level of fixed loans among American homeowners and businesses suggests the economy there hasn’t yet seen the full impact of higher rates.

But this will happen over time, which means the market will be range-bound Sandler says. And this means stock pickers will have to work harder in order to deliver outsized returns.

“I think everyone is focused on a soft landing or where’s inflation going to fall and where interest rates are going. Nobody’s focused on picking interesting, idiosyncratic stocks.

“I think the system is healthy enough that I’m not worried about something really bad happening. So we can play offence.”

The Australian is a media partner of Sohn Hearts and Minds.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on 11 September 2023. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Disclaimer: This material has been prepared by The Australian, published on Sep 11, 2023. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍
November 6, 2024

Why this New York hedge fund manager sees opportunity in European stocks

Influential New York-hedge fund manager Ricky Sandler will turn to Europe for his next stock pick.

Read More
Vihari Ross of Antipodes. Picture: Louie DouvisVihari Ross of Antipodes. Picture: Louie DouvisVihari Ross of Antipodes. Picture: Louie DouvisVihari Ross of Antipodes. Picture: Louie Douvis
November 5, 2024

Antipodes’ Ross says short-term wealth hinges on US election

The portfolio manager says defensive stocks pose a bigger risk than the magnificent seven for investors that are overexposed to the American sharemarket.

Read More
Antipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John FederAntipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John FederAntipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John FederAntipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John Feder
November 5, 2024

Concentration risk key for investors: Antipodes Partners’ Vihari Ross

The concentration risk in global stock indexes that has built up during the strong rise over the past year must now be a key consideration for global investors, according to Vihari Ross.

Read More
JO Hambro Asset Management senior portfolio manager Samir Mehta.JO Hambro Asset Management senior portfolio manager Samir Mehta.JO Hambro Asset Management senior portfolio manager Samir Mehta.JO Hambro Asset Management senior portfolio manager Samir Mehta.
November 5, 2024

The fundie betting big on China – with help from AI

Mr Mehta is sticking to his well-worn strategy: he’s hunting for companies across Asia that aren’t battling intense competition and have management teams focused on costs, cash generation and high payouts to shareholders.

Read More
Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.
October 29, 2024

Why this fundie wants you to ‘wince’ at his stock picks

When fund managers come to pitch their favourite stock at the annual Sohn Hearts & Minds conference, there are two ways they can go: they can play it safe, or they can take a risk and shock the room.

Read More
October 27, 2024

IFM Investors’ Rikki Bannan backs small cap investments to rebound after mixed performance

IFM Investors executive director Rikki Bannan believes this year could be a good one to invest in some select small cap stocks.

Read More
October 22, 2024

Meet the 2024 Conference Managers

Following a global search, the Conference Fund Manager Selection Committee is pleased to share eleven new managers for 2024.

Read More
October 21, 2024

Chris Kourtis is on a winning streak. Here’s his next ASX pick

Chris Kourtis of Ellerston Capital thinks he’s found another winner and thinks it’s the last chance to have a bite at the cherry before the strategy plays out.

Read More
Ellerston Capital portfolio manager Chris Kourtis. Picture: Britta CampionEllerston Capital portfolio manager Chris Kourtis. Picture: Britta CampionEllerston Capital portfolio manager Chris Kourtis. Picture: Britta CampionEllerston Capital portfolio manager Chris Kourtis. Picture: Britta Campion
October 21, 2024

Why Ellerston Capital’s Chris Kourtis plans to back a ‘hated’ stock

Chris Kourtis of Ellerston Capital plans to tip one of the “most hated” stocks in Australia when he presents at the 2024 Sohn Hearts & Minds Conference.

Read More
 ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion
October 14, 2024

Alex Pollak champions rewards of disruptive investment

Alex Pollak’s funds management company Loftus Peak rode the Nvidia wave and he is now looking at more opportunities in disruptive industry stocks.

Read More
October 8, 2024

Sumit Gautam - Why AI won't deliver in 2025 | Scalar Gauge

Sumit Gautam is the Founder of Scalar Gauge and speaks with Equity Mates ahead of his appearance at the Sohn Hearts & Minds conference.

Read More
September 30, 2024

Missed out on Nvidia and Ozempic? This fundie says it’s never too late

Northcape Capital’s Fleur Wright is still kicking herself for not owning market darlings Nvidia and Novo Nordisk, the maker of the weight loss wonder drug Ozempic, before shares of those companies rocketed in 2023.

Read More
September 23, 2024

Scalar Gauge Fund founder Sumit Gautam cautious about over-hyped AI

Tech investor Sumit Gautam carefully avoids the word bubble when describing the investor frenzy surrounding the rise of artificial intelligence, but warns there are dangers of getting caught up in the hype.

Read More
September 9, 2024

The Wellcome Trust’s Nick Moakes made a 100-year bet. It’s paying off

Chief Investment Officer, Nick Moakes raised almost $3 billion at ultra-low rates. Sometimes the long view can be the most profitable.

Read More
Wellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven Pocock
September 5, 2024

Honesty the only policy that matters, says Wellcome Trust’s Nicholas Moakes

The chief investment officer of the London-based $71bn Wellcome Trust, Nick Moakes, has a simple rule for the trust’s investment team: “Never invest with anyone who is or has been or should have been in prison.”

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.